Insider Trading History of Poyhonen John

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Poyhonen John since 2005. This trader's CIK number is 1286100. At the time of last reporting, Poyhonen John was the President & CCO of Heron Therapeutics, Inc. /de/. (stock ticker symbol HRTX). Also see all insider trading activities at Heron Therapeutics, Inc. /de/.

Note that in the past POYHONEN JOHN also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Senomyx Inc (SNMX) by Poyhonen John

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2017 SNMX 50,000 $49,035 0 $0 0 $0
2014 SNMX 0 $0 37,600 $300,800 37,600 $226,351
2007 SNMX 0 $0 22,380 $309,866 0 $0
2006 SNMX 0 $0 20,966 $311,225 0 $0
2005 SNMX 0 $0 8,666 $145,679 0 $0

Yearly summary of insider trading at Heron Therapeutics, Inc. /de/ (HRTX) by Poyhonen John

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 HRTX 0 $0 0 $0 11,628 $0
2022 HRTX 0 $0 0 $0 17,442 $0
2021 HRTX 0 $0 0 $0 3,750 $0
2019 HRTX 8,143 $142,652 0 $0 0 $0
2017 HRTX 10,000 $122,000 0 $0 0 $0

Yearly summary of insider trading at Intrabiotics Pharmaceuticals Inc /de (RDEA) by Poyhonen John

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2011 RDEA 0 $0 5,500 $135,730 5,500 $32,175
2010 RDEA 0 $0 4,000 $92,064 4,000 $23,400
2009 RDEA 0 $0 8,000 $121,709 8,000 $46,800


Insider trading activities at 3 companies by Poyhonen John:

1. Senomyx Inc (SNMX)

2. Heron Therapeutics, Inc. /de/ (HRTX)

3. Intrabiotics Pharmaceuticals Inc /de (RDEA)

Table 1. Insider trading of Senomyx Inc (SNMX) by Poyhonen John

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2017-03-22 SNMX Buy 35,000 .98 34,230
2017-03-23 SNMX Buy 15,000 .99 14,805
2014-06-05 SNMX Option Ex 37,600 6.02 226,351
2014-06-05 SNMX Sale 37,600 8.00 300,800
2007-09-04 SNMX Sale 943 13.25 12,492
2007-06-15 SNMX Sale 10,800 14.84 160,315
2007-05-15 SNMX Sale 2,400 12.47 29,925
2007-04-16 SNMX Sale 5,837 13.08 76,342
2007-01-16 SNMX Sale 2,400 12.83 30,792
2006-11-15 SNMX Sale 4,800 14.88 71,438
2006-09-15 SNMX Sale 1,500 15.04 22,561
2006-08-15 SNMX Sale 1,500 13.40 20,107
2006-07-17 SNMX Sale 1,500 13.11 19,660
2006-05-15 SNMX Sale 1,500 12.78 19,165
2006-04-17 SNMX Sale 1,500 14.58 21,870
2006-03-15 SNMX Sale 1,500 15.78 23,670
2006-03-01 SNMX Sale 4,166 16.43 68,434
2006-02-15 SNMX Sale 1,500 15.50 23,250
2006-01-17 SNMX Sale 1,500 14.05 21,070
2005-12-15 SNMX Sale 1,500 12.70 19,050
2005-11-15 SNMX Sale 1,500 14.60 21,901
2005-10-17 SNMX Sale 1,500 13.90 20,857
2005-08-15 SNMX Sale 2,083 19.11 39,795
2005-07-26 SNMX Sale 2,083 21.16 44,076

Table 2. Insider trading of Heron Therapeutics, Inc. /de/ (HRTX) by Poyhonen John

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-04-13 HRTX Option Ex 5,814 .00 0
2023-01-13 HRTX Option Ex 5,814 .00 0
2022-07-13 HRTX Option Ex 5,814 .00 0
2022-04-13 HRTX Option Ex 5,814 .00 0
2022-01-13 HRTX Option Ex 5,814 .00 0
2021-10-13 HRTX Option Ex 1,250 .00 0
2021-07-13 HRTX Option Ex 1,250 .00 0
2021-01-13 HRTX Option Ex 1,250 .00 0
2019-10-03 HRTX Buy 5,143 17.50 90,002
2019-05-22 HRTX Buy 3,000 17.55 52,650
2017-01-19 HRTX Buy 10,000 12.20 122,000

Table 3. Insider trading of Intrabiotics Pharmaceuticals Inc /de (RDEA) by Poyhonen John

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2011-06-03 RDEA Option Ex 500 5.85 2,925
2011-06-02 RDEA Option Ex 5,000 5.85 29,250
2011-06-03 RDEA Sale 500 24.50 12,250
2011-06-02 RDEA Sale 5,000 24.70 123,480
2010-09-23 RDEA Option Ex 4,000 5.85 23,400
2010-09-23 RDEA Sale 4,000 23.02 92,064
2009-05-19 RDEA Option Ex 5,000 5.85 29,250
2009-05-20 RDEA Option Ex 3,000 5.85 17,550
2009-05-19 RDEA Sale 5,000 15.34 76,700
2009-05-20 RDEA Sale 3,000 15.00 45,009

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Poyhonen John (President & CCO of Heron Therapeutics, Inc. /de/ at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.